Their Objective

Scaling Meta Ad Performance While Staying Privacy Compliant

AgelessRx, a fast-growing telehealth platform, ran into critical challenges such as:

• Weak EMQ signal (~5), limiting Meta’s optimization effectiveness
• Duplicate events from disconnected server and client data, which hurt attribution accuracy
• Delays in creative testing due to inconsistent signal reliability
• Needing to future-proof against Meta’s evolving privacy and compliance requirements

“Even before Meta’s new health restrictions, we had a signal strength problem. Meta’s CAPI helped, but it wasn’t unified. That’s where Blotout came in.”

‍

The Solution

Laying the Foundation for Scalable, Privacy-Compliant Growth

With Blotout’s help, AgelessRx:

• Increased EMQ score from ~5 to 7–8, enabling more efficient Meta delivery
• Improved CAC efficiency by 10–20% through higher-quality targeting and attribution
• Doubled Meta ad spend in Q1 with confidence in performance data
• Moved away from 1-day view attribution, focusing on high-LTV customer segments

‍

The Results

Driving Performance at Scale with Trusted Signal Quality

Within one fiscal quarter of using Blotout, AgelessRx:

• Increased EMQ score from ~5 to 7–8, enabling more efficient Meta delivery
• Improved CAC efficiency by 10–20% through higher-quality targeting and attribution
• Doubled Meta ad spend in Q1 with confidence in performance data
• Moved away from 1-day view attribution, focusing on high-LTV customer segments

'With a unified data foundation and stronger signal integrity, AgelessRx unlocked the scale, efficiency, and confidence needed to grow sustainably on Meta—without compromising on compliance.'

‍